Consistent with the tumor growth inhibition, anti-PD-L1 therapy promoted the tumor accumulation of CD8+ T cells and the combination of PD-L1 blockade and CD4+ T cell depletion further increased the proportion of intratumoral CD8+ T cells (Figure 6(a) and Supplementary Figure S13, S14). This evidence concerns the gene CD8A and neoplasm.